Daily short message service surveys detect greater HIV risk behavior than monthly clinic questionnaires in Kenya

Similar documents
Timothy R Muwonge on behalf of Co-Authors

Prevention-Effective Adherence per SMS Surveys within a Demonstration Project of PrEP among HIV Serodiscordant Couples in East Africa

An adherence intervention to support HIV pre-exposure prophylaxis (PrEP) adherence in HIV serodiscordant couples in Uganda

Counseling Framework for HIV-serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-Exposure Prophylaxis for HIV Prevention

Christina Psaros, Ph.D. (presenting author) Massachusetts General Hospital / Harvard Medical School, Boston, MA

Safer conception intervention to reduce HIV risk for Kenyan HIV serodiscordant couples with immediate fertility needs (preliminary findings)

CROI 2015: HIV Prevention Updates

young women in rural Kenya: a pilot study Njambi Njuguna A thesis submitted in partial fulfillment of the requirements for the degree of

Shebeen Attendees Perceptions of HIV Pre-Exposure Prophylaxis (PrEP) in KwaZulu-Natal Province, South Africa

Adolescent PrEP Delivery: Strategies and Tools to Maximize Adherence Young Women in Africa. Jessica Haberer, MD, MS November 9, 2017

Use of a risk scoring tool to identify higherrisk HIV-1 serodiscordant couples for an antiretroviral-based HIV-1 prevention intervention

Factors influencing adherence behavior for daily and intermittent regimens of PrEP among MSM in Kenya

PrEP in young African women: Rationale & lessons from HPTN 082

HIV Prevention and Reproductive Choices

Antiretroviral-Based HIV Treatment and Prevention Strategies: Advancing Science into Practice

Interventions to improve PrEP and ART uptake and adherence among adolescent girls and young women. Jessica Haberer, MD, MS 26 April 2018

QUESTIONS AND ANSWERS ABOUT PARTNERS PrEP AND VOICE

PrEP in young African women: Rationale & lessons from HPTN 082 (and other studiesp

The Open Label Trial Past and Present

Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention

Translating the Science to End New HIV Infections in Kenya

Efficacy of preexposure prophylaxis for HIV-1 prevention among high-risk heterosexuals: subgroup analyses from a randomized trial

Antiretroviral Drugs for HIV Seronegative People: It works in trials, what about the real world?

The Acceptability and Impact of a Weekly Text-Messaging Program to Support HIV Treatment Adherence in KwaZulu-Natal, South Africa

Hormonal contraception and HIV risk

Drug development in relation to PrEP and the PROUD study

Understanding the Results of VOICE

What We Will Learn From the REACH Study

The potential impact of partially effective HIV prevention strategies: Insights from mathematical modeling analyses

Systematic review ALHIV: Disclosure, adherence and retention in care

Key words: YIDUs, condom use behaviour

Informed Consent Flipchart. Version 1.0, 30 Jan 2018

PrEP for Women: HIV Prevention in Family Planning Settings

PrEP 201: Beyond the Basics

Female HIV acquisition per sex act is elevated in late pregnancy and postpartum

Biomedical Prevention Update Thomas C. Quinn, M.D.

HIV Pre- Exposure Prophylaxis

Guidelines on safer conception in fertile HIV infected individuals

So you have HIV and you want to have a baby?

Behavioral Research in the Microbicide Trials Network

Partner violence and self-reported pre-exposure prophylaxis (PrEP) interruptions among HIV

Annex 2: GRADE evidence profiles

Impact of Text-Messaging (SMS) Programs for Improving Antiretroviral Adherence in Kenya

Supporting Effective PrEP Pill Taking and Providing HIV Risk Reduction Counselling.

mobile Vulnerability Analysis & Mapping for nutrition: Kenya case study

PrEP: Pre Exposure Prophylaxis

HIV: Pregnancy in Serodiscordant Couple. Dr Chow TS ID Clinic HPP

About FEM-PrEP. FEM-PrEP is also studying various behaviors, clinical measures, and health outcomes among the trial s participants.

Contraception & HIV Still searching for answers after >2 decades

University of California San Francisco, 2 University of Miami, 3 Northwestern University

DOES HORMONAL CONTRACEPTION INCREASE HIV ACQUISITION RISK AMONG ZAMBIAN WOMEN IN DISCORDANT COUPLES?

The Science behind Preexposure Prophylaxis (PrEP) Yunus Moosa Department of Infectious Diseases UKZN

THE EFFECT OF VCT TESTING AND UPTAKE OF HIV/ART CARE ON MODERN CONTRACEPTIVE USE AMONG WOMEN IN RAKAI, UGANDA

The Open Label Trial Past and Present

Clinical Policy Title: Pre-exposure prophylaxis for HIV prevention

Conference Item (paper)

HIV PREP THE NEWEST TOOL IN THE BOX

The ENRICH Study Evaluating an Innovative Approach to Increasing Use of Isoniazid Preventive Therapy to Prevent TB among People Living with HIV

WHO consultation on PrEP adherence

PrEP Implementation in San Francisco. Michael Barajas- Citywide PrEP Navigator San Francisco City Clinic San Francisco Department of Public Health

during conception, pregnancy and lactation at 2 U.S. medical centers

PrEP uptake among pregnant and postpartum women: results from a large implementation program within maternal child health (MCH) clinics in Kenya

Novel HIV Prevention Methods for Women

Use of Pre-exposure Prophylaxis (PrEP) in pregnancy for primary prevention of HIV infection in women

Entendiendo la ciencia para acabar con el VIH en América Latina y el Caribe

PDXScholar. Portland State University. Alexander Kintu Harvard School of Public Health

Importance of Viral Suppression to Reduce HIV Transmission: Recent Evidence

Case Studies in PrEP Management. Kevin L. Ard, MD, MPH Massachusetts General Hospital, National LGBT Health Education Center April 15, 2016

CCTs and HIV care: Preliminary results and priority areas for intervention

Microbicides and Antiretroviral Therapy

PRECONCEPTION COUNSELING

Cellphones4HIV Mobiles in health in South Africa

The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial

MTN-020. Jared Baeten, MD PhD Thesla Palanee, PhD On behalf of the ASPIRE team MTN Annual Meeting, Bethesda 21 February 2012

The effects of providing fixed compensation and lottery-based rewards on uptake of medical male circumcision: a randomized trial

Hormonal contraceptive methods & HIV acquisition in women: updated systematic review of epidemiological evidence

Getting Prepped for PrEP. Ken Ho, MD, MPH World AIDS Day

PSYCHOSOCIAL PREDICTORS OF ACCEPTABILITY

Psychosocial Issues in ART and HIV Prevention. Steven A. Safren, PhD

HIV status and fertility desires, contraceptive use, and pregnancy rates in Rakai, Uganda

HIV PREVENTION. ETHICAL CONSIDERATIONS IN DEVELOPING AN EVIDENCE BASE FOR PrEP IN PREGNANT WOMEN

Where are we going after effectiveness studies?

Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study

Sexually transmitted disease prevention: knowledge, attitudes, and practices among school pupils in rural Ghana

PrEP in the Real World: Clinical Case Studies

HPTN 061: The Brothers Study

A Self-Reported Adherence Measure to Screen for Elevated HIV Viral Load in Pregnant and Postpartum Women on Antiretroviral Therapy

Planned Vaccine Trials to Follow-up on RV 144. Merlin Robb, MD Deputy Director for Clinical Research MHRP

Using Plasma Viral Load to Guide Antiretroviral Therapy Initiation to Prevent HIV-1 Transmission

Sexual behaviour of heterosexual men and women receiving antiretroviral pre-exposure prophylaxis for HIV prevention: a longitudinal analysis

HIV Prevention Strategies HIV Pre-exposure prophylaxis

Counselling Should: Recognize that behaviour change is difficult and human beings are not perfect

Supplementary Material Table 5. Ongoing PrEP studies among young key population, young people, and key populations. Age range. Study name and location

Sex, risk and incentives: The effect of new HIV prevention products on the market for commercial sex in South Africa

Nsambya Rubaga Jinja Source: National AIDS Programme, Figure 1. HIV infection rates among pregnant women. Selected sites

PrEP Dosing Strategies

HIV treatment interruptions are associated with heightened biomarkers of inflammation, coagulopathy and T-cell activation despite viral suppression

The Evidence Base for Women

QUALIAIDS TEAM STUDIES IN BRAZIL

Options in HIV Prevention A Participant-Centered Counseling Approach

Transcription:

Daily short message service surveys detect greater HIV risk behavior than monthly clinic questionnaires in Kenya Kathryn Curran, Nelly Mugo, Ann Kurth, Kenneth Ngure, Renee Heffron, Deborah Donnell, Connie Celum, Jared Baeten

Disclosures I have no conflicts of interest to report.

New Technology for Health Mobile phones are common in Africa In Kenya: 26 million own mobile phones (pop. 41 mil) 1 18 million use phones for banking, business, paying bills 1 1 Talbot 2012

New Technology for Health Mobile technology for health in Africa SMS reminders for ART adherence 1,2 SMS to collect health data from patients 3,4 Short message service (SMS, i.e. text message) may reduce measurement bias Recall & social desirability bias 1 Lester 2010, 2 Pop-Eleches 2011, 3 Haberer 2010, 4 Mark 2010

Study Aim Objective: To compare PrEP adherence & sexual behavior data collected through daily SMS surveys to monthly intervieweradministered questionnaires Hypothesis: Daily SMS surveys reduce recall & social desirability biases & yield greater reports of unprotected sex missed PrEP doses

Context: The Partners PrEP Study Randomized controlled trial of PrEP among 4,758 HIV serodiscordant couples in 9 sites in Kenya & Uganda SMS Survey at Thika, Kenya site December 2011- April 2012, when PrEP known to be efficacious

Context: Daily SMS Surveys Eligibility criteria: HIV-uninfected & taking PrEP Literate Owned a mobile phone Knew how to send & receive SMS Regular access to electrical outlet High response rate ( 5 daily surveys) during week 1 Automated daily SMS surveys for 60 days Compensated with airtime 2x week

Context: Daily SMS Surveys 1 SMS data collection of sensitive health information is feasible & acceptable High response rates (>90%) Self-reported PrEP adherence was high Sexual activity a strong predictor Not associated with unprotected sex Self-reported unprotected sex was infrequent, but common (~50% ever) Difficulty predicting sex 1 Curran 2013

Sex Condom use PrEP use Daily SMS Survey Did you have sex yesterday? Did you or your partner use a condom when you had sex? Did you remember to take your study pill yesterday? Monthly Clinic Questionnaire In the past month, how many times did you have sexual intercourse with your study partner? with someone other than your study partner? How many times was a condom used? (# with study partner + # with another partner) In the past month, how many days did you take neither of the study tablets? Monthly clinic visit Observation Month median (range) = 28 (23-34) days Monthly clinic questionnaire Daily SMS survey

Statistical Methods To compare reports for any missed PrEP, any sex & any unprotected sex: Percent agreement McNemar s Chi 2 To compare reports for number of missed PrEP doses, sex acts & unprotected sex: Concordance correlation coefficients Generalized linear latent and mixed models to calculate incidence rate ratios for count outcomes

SMS Study Participants Included in Comparison Analysis 94 participants had > 1 monthly clinic visit during SMS survey enrollment 179 monthly clinic visits during enrollment in SMS study 145 monthly clinic visits among 85 participants included for comparison to SMS survey data 34 monthly clinic visits excluded: 8 had <21 days or >35 days between clinic visits 26 had <21 SMS surveys completed between clinic visits

Participant Characteristics (N=85) N (%) or Median (IQR) Male 65 (76.5%) Age, years 33 (31-37) Married 82 (96.5%) More than one wife* 7 (8.2%) Living with study partner 81 (95.3%) Number of children with study partner 1 (0-2) Number of years in school 11 (8-12) Earning any income 80 (94.1%) Running water in the home 39 (44.9%) Time spent in Partners PrEP Study, years 2.2 (1.7-2.4) Weekly alcohol use reported at Partners PrEP Study enrollment 21 (24.7%) HIV-infected study partner on antiretroviral therapy** 26 (30.6%) Reported sex with someone other than study partner, past month** 7 (8.2%) *Reported through interviewer-administered questionnaire at clinic visit prior to enrollment in SMS survey.

Frequency of Reporting Any Sex, Any Unprotected Sex & Any Missed PrEP, by Survey Method (n=145) All significantly greater over daily SMS, according to McNemar s Chi 2 test statistic at P<0.01

Comparison of Daily SMS Surveys & Monthly Questionnaires (n=145) Daily SMS Median (Range) Monthly Questionnaire Median (Range) Incidence Rate Ratio (95% CI) P Concordance Correlation Coefficient Number of sex acts 9 (0-32) 5 (0-22) 1.5 (1.3-1.7) <0.00 1 0.5 Number of unprotected sex acts 0 (0-14) 0 (0-21) 1.2 (0.8-1.8) 0.4 0.6 Number of missed PrEP doses 1 (0-7) 0 (0-5) 5.1 (3.0-8.5) <0.00 1 0.10

Study Limitations Small, selected population limits generalizability Clinical trial, literate, owned phone, high response during week 1 Survey questions serve as reminders for condom use & adherence Accuracy of self-reported behaviors unknown

Key Findings Sex, unprotected sex, & missed PrEP doses reported on more days through daily SMS surveys 24% of observations-months had reports of unprotected sex & 45% had any missed PrEP by SMS but not by monthly questionnaire Most likely reflects under-reporting on monthly questionnaires Both methods: majority report perfect PrEP adherence or small number of missed PrEP doses Daily SMS surveys may capture more frequent reports of HIV risk behavior, greater accuracy

Summary & Implications SMS may offer new method for measuring behaviors related to HIV risk & adherence Privacy, reduced recall period Greater reporting of HIV risk behaviors & non-adherence Examine patterns of risk and pill-taking Capture behaviors in real-time to enable response Large-scale daily SMS survey of PrEP adherence & sexual behavior in Partners Demonstration Project in Kenya & Uganda 1 week before, 1 week after quarterly clinic visits Consider research question, timing, literacy, & cost

Acknowledgments Partners PrEP Study team Study participants Dimagi Funding: National Institutes of Health R21 NR012663, D43 TW000007 & T32 AI07140 Bill & Melinda Gates Foundation Tuesday, 10:15am: Session 12, Oral Abstract 317, Jessica Haberer Adherence to PrEP in the Partners Demonstration Project

Thank you!

Survey Questions Daily questions: 1. What is your secret password? 2. Did you have sex yesterday? 3. Did you or your partner use a condom when you had sex? 4. Do you think you will have sex tomorrow? 5. Did you remember to take your study pill yesterday? Please respond 1: yes, 2: no, 3: I choose not to respond.

Flow of Enrollment 206 approached 110 enrolled 17 declined 79 ineligible 4 illiterate 28 no phone / shares phone 42 didn t know how to send SMS 5 no access to electrical outlet 14 failed during week 1 run-in 96 followed for 60 days Respond to <5 of 7 surveys

Participant Characteristics (N=96) N (%) or Median (IQR) Male 72 (75.0%) Age, years 33.3 (30.9 37.3) Married 93 (96.9%) Living with study partner 91 (94.8%) Number of children with study partner 1 (0-2) Number of years in school 11 (8-12) Electricity available in the home 46 (48.9%) Time spent in Partners PrEP Study, years 2.1 (1.7-2.4) HIV-infected study partner on antiretroviral therapy* 29 (30.2%) Number of sex acts, prior month* 4 (2-8) Any unprotected sex with study partner, prior month* 8 (8.3%) Any sex with other partners, prior month* 7 (7.3%) Any unprotected sex with any sexual partner, prior month* 13 (13.5%) *Reported through interviewer-administered questionnaire at clinic visit prior to enrollment in SMS survey.

SMS Survey Response Rates 96 participants * 60 days = 5,760 surveys planned 5,412 surveys distributed 327 surveys not answered 5,085 surveys answered (94.0% of surveys distributed)